New York, NY -- (SBWIRE) -- 12/09/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Delcath Systems, Inc (NASDAQ:DCTH), Inovio Pharmaceuticals Inc (NYSEMKT:INO), NanoTech Entertainment, Inc (OTCMKTS:NTEK), America Movil SAB de CV (ADR) (NYSE:AMX)
Delcath Systems, Inc (NASDAQ:DCTH) showed a volume of 3.78 million shares by the end of last trade whereas the average volume of the stock remained 1.17 million shares. The stock opened the session at $0.28 but then moved to $0.260. At that price, the stock showed a negative performance of -5.63%. Delcath Systems, Inc. (Delcath) is a development-stage, specialty pharmaceutical and medical device company, focused on oncology, initially cancers in the liver. Delcath focuses on the development and clinical study of the Delcath chemosaturation system. The Delcath chemosaturation system allows the administration of concentrated regional chemotherapy by isolating the circulatory system of the targeted organ. Once the organ is isolated, the Delcath chemosaturation system delivers doses of chemotherapeutic agents directly to the liver.
Will DCTH Get Buyers Even After The Recent Rally? Find Out Here
Inovio Pharmaceuticals Inc (NYSEMKT:INO) opened the session at $2.04 and closed the session at $1.98. The stock showed a negative performance of -2.94% in previous trading session. Traded with volume of 2.21 million shares in the prior session and the average volume of the stock remained 2.79 million shares. Inovio Pharmaceuticals, Inc. is engaged in the development of a new generation of vaccines, called synthetic vaccines, focused on cancers and infectious diseases. The Company's SynCon technology enables the design of universal vaccines capable of providing cross-protection against existing or changing strains of pathogens, such as influenza and human immunodeficiency virus (HIV). The Company's electroporation delivery technology uses brief, controlled electrical pulses to increase cellular uptake of the vaccine.
Has INO Found The Bottom And Ready To Gain Momentum? Find Out Here
NanoTech Entertainment, Inc (OTCMKTS:NTEK) opened the session at $0.12 and closed the session at $0.123. The stock showed a negative performance of -0.81% in previous trading session. Traded with volume of 7.21 million shares in the prior session and the average volume of the stock remained 5.78 million shares. The beta of the stock remained 1.50. NanoTech Entertainment, Inc. (NanoTech), formerly Aldar Group, Inc., is a provider of gaming technology for the coin-op arcade, casino gaming and consumer gaming markets. The Company operates as a manufacturer, developing technology and games, and then licensing them to third parties for manufacturing and distribution. As of June 30, 2009, the Company’s products included MultiPin, Xtreme Rally Racing, NanoNET Online System, Pinball Wizard, Mot-Ion Adapter, Opti-Gun Adapter and Retr-IO Adapter.
Why Should Investors Buy NTEK After the Recent Fall? Just Go Here and Find Out
America Movil SAB de CV (ADR) (NYSE:AMX) the stock advanced 0.27% and finished the session at $22.25. Traded with volume of 9.99 million shares in the prior session and the average volume of the stock remained 8.00 million shares. The beta of the stock remained 1.22. America Movil SAB de CV is a Mexico-based company primarily engaged in the provision of wireless communications services in Latin America. The Company’s activities include mobile and landline telephony services, broadband access, as well as cable and satellite television. It distributes its services under the Telcel, Telmex, Comcel, Claro, Embratel, Net and TracFone brands. As of December 31, 2011, the Company owned such subsidiaries as Radiomovil Dipsa SA de CV, Telefonos de Mexico SAB de CV, Comunicacion Celular SA,
Will AMX Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)